News for EMvision Medical Devices Limited (EMV.AX)

Australian MedTech company Ceretas has successfully secured $1 million in seed funding to advance its low-cost, portable and non-invasive ultrasound

It’s starting to look like a flat Wednesday, with Aussie futures now…

Australian Medtech EMVision Unveils Backpack-Sized Brain Scanner to Empower First Responders

EMVision Medical Devices (ASX:EMV) has announced its successful fabrication of a portable on-the-spot brain scanning device.

Stage 2 interim data from a pre-validation trial by EMVision Medical Devices (ASX: EMV) has confirmed the positive performance of neurodiagnostic

EMVision Medical Devices (ASX:EMV) has revealed the name of its inaugural point-of-care brain scanner device, 'emu', at the RSNA 2023 conference.

EMVision Medical Devices (ASX:EMV) has assembled an advanced 28-antenna prototype of its second-generation helmet scanner.

Welcome to Tuesday of the trading week. ASX futures were down 15 points or 0.2 per cent at 7:00 am AEDT following overnight global sessions.

EMVision Medical Devices (ASX:EMV) has updated shareholders that all three of its clinical trial sites are now enrolling.

The ASX is expected to open flat today after the US Federal Reserve hiked interest rates once again to a 22-year high of 5.5 per cent.

The ASX 200 rallied as much as 100 points in early trade, before paring back its advance to 62.6 points.

ASX is set to rise today. Overnight, Wall St rallied again with all three major benchmarks (S&P 500, Dow Jones and Nasdaq) rising by 1% each.

Where is super prospector Mark Creasy looking next, three lithium producers catching Argonaut’s eye and James Whelan's found someone backing Cathie Wood.

Guy Le Page's Galileo nearology special, all you need to know about ASX silver stocks, and an early winner declared in the ESG nickel race.

Anaemic data out of China has taken the fun out of Monday here in Sydney. April retail sales in the Middle Prison plummeted by more than 11%

The top 50 ASX miners and explorers for April, Claude Walker's favourite small caps, and nuclear fusion laser player is cashed up.

The small caps that won and lost in April, the commodities that won and lost in April, and the BNPLs that- wait... some BNPLs won?

EMVision Medical Devices (ASX: EMV) has announced its device development and multi-centre clinical trial preparation is progressing positively, with the company capping off its latest quarter being well funded.